January 26, 2012 — The RhinoChill IntraNasal cooling system has been nominated for one of the European medical device industry’s most prestigious awards.
The RhinoChill system has been shortlisted for the Critical Care and Emergency Medicine Product of the Year category prize in the first MEDTEC EMDT Innovation Awards. The awards are the only European awards dedicated to recognizing achievements in the sector.
Despite being successfully resuscitated, two out of three people who suffer a cardiac arrest die as a result of brain damage. Therapeutic hypothermia – a medically-induced lowering of body temperature – has been shown to improve survival rates and quality of life for resuscitation survivors. However, for every hour’s delay in initiation of brain cooling, the risk of death increases by 20 percent.
RhinoChill is an easy-to-use, non-invasive portable cooling system which enables effective therapeutic hypothermia to be initiated as early as possible following cardiac arrest, even before the return of normal circulation. It has been shown to help preserve the brains of cardiac arrest victims.
Gregor Bischkopf, group event manager of UBM Canon, commented, “The MEDTEC EMDT Awards are now in their first year and the quality and quantity of the entries is fantastic. Making the shortlist is a substantial achievement for all the companies involved due to the high caliber of entries. However, we would also like to thank all the people who took the time to enter this year. I look forward to seeing the finalists in Stuttgart in March.”
“These awards are regarded as a universal benchmark of quality within the medical device industry,” said BeneChill CEO Fred Colen. “Being shortlisted for RhinoChill is a tremendous achievement.”
This year’s winners will be announced at a ceremony at the Messe Stuttgart on March 14, 2012.
For more information: www.benechill.com, www.medteceurope.com